TEMODAR
NDC 0085-1417, Temozolomide, capsule, from Merck Sharp & Dohme LLC.
- Product NDC
- 0085-1417
- Status
- Listed
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021029
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0085-1417 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TEMOZOLOMIDE250 mg/1
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0085-1417-02 | 00085141702 | 5 PACKET in 1 CARTON (0085-1417-02) / 1 CAPSULE in 1 PACKET (0085-1417-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/046a9011-3911-4d3f-a15f-fbb56d5aad56
Use it
Look up 0085-1417 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0085-1417 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0085-1417. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.